Antibacterial Drugs and the Risk of Community-Associated Methicillin-Resistant Staphylococcus aureus in Children

Proportion of MRSA human blood isolates from participating countries in 2008***

From the 14 December edition of Full Text Reports

Antibacterial Drugs and the Risk of Community-Associated Methicillin-Resistant Staphylococcus aureus in Children

Source:  Archives of Pediatrics & Adolescent Medicine

Objective
To investigate in children the association between antibacterial drugs and subsequent diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) in the community.

Design
Population-based case-control study in children 1 to 19 years of age.

Setting
Primary care, General Practice Research Database, United Kingdom, 1994-2007.

Participants
Cases were children who had MRSA diagnosed as outpatients, and controls were individually matched on age and practice, with the matched case’s diagnosis date as the index date for both.

Main Exposures
Antibacterial agents prescribed 180 to 30 days prior to the index date, excluding prescriptions 30 days before the index date to prevent protopathic bias.

Outcome Measures
Rate ratios (RRs) estimated from the odds ratios of exposure in cases compared with controls using conditional logistic regression, adjusted for comorbid conditions, other prescription drug use, and hospitalization.

Results
The rate of MRSA was 4.5 per 100 000 per year. Of 297 cases and 9357 controls, 52.5% and 13.6%, respectively, received antibacterial drug prescriptions during the 150-day exposure window. The adjusted RR with any antibacterial drug was 3.5 (95% confidence interval [CI], 2.6-4.8). The RRs increased with the number of prescriptions (2.2 [95% CI, 1.5-3.2], 3.3 [95% CI, 1.9-5.6], 11.0 [95% CI, 5.6-21.6], and 18.2 [95% CI, 9.4-35.4] for 1, 2, 3, and 4 prescriptions, respectively). The RR was particularly elevated for quinolones at 14.8 (95% CI, 3.9-55.8), with wide variation among antibacterial classes.

Conclusion
While close to half of children were diagnosed as having MRSA in the community without prior antibacterial drugs, such agents are associated with a dose-dependent increased risk, concordant with findings in adults.

***Image from http://commons.wikimedia.org/wiki/File:EARSS_MRSA_2008.sv, Institute for Public Health and the Environment (RIVM), Epidemiology and Surveillance, 3720 BA Bilthoven,The Netherlands

 

Related Resources

• MRSA (MedlinePlus) A general guide with links to overviews, diagnosis/symptoms, specific conditions, news items, and more
• MRSA Infection (eMedicine Health)  A patient/consumer guide with links to diagnosis/symptoms, risk factors, images, and slideshows
• Methicillin-resistant Staphylococcus Aureus (MRSA) Infections (CDC) Comprehensive guide with links to definition, symptoms, prevention, people at risk, environmental cleaning, statistics, and educational resources

   

Related articles

Disclaimer: Links below are for informational/awareness only

                            The inclusion of any article here does not necessarily mean agreement with this author’s beliefs 

• MRSA In Children: Do You Know The Signs? (vintagevicki.com)
• Pimples (and Rosacea) Link to MRSA (tfollowers.com)
• MRSA found in Iowa meat (scienceblogs.com)
• Forget MRSA, Fear VRSA (alternativendhealth.wordpress.com)
• MRSA: From A Nosocomial Pathogen To An Omnipresent Source Of Infection (medicalnewstoday.com)
• More MRSA Found In U.S. Retail Meat (Turkey, Too) (wired.com)